{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Andover",
      "state": "MA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "89742",
      "recalling_firm": "Philips Healthcare",
      "address_1": "3000 Minuteman Rd",
      "address_2": "N/A",
      "postal_code": "01810-1032",
      "voluntary_mandated": "FDA Mandated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide Distribution",
      "recall_number": "Z-0734-2022",
      "product_description": "Azurion systems with software release R2.0.x",
      "product_quantity": "69 systems",
      "reason_for_recall": "In the Azurion system, the user can add a new study to a patient by selecting the option \"Add Study\".  The Add Study dialogue box is then displayed where the Patient Type is selected to perform the  study. Due to a software defect, when the study is initiated by pressing  Start Procedure , the Patient Type changes inadvertently to a Patient Type different than the one selected as shown in the Table below. Patient type is one of the factors involved in the dose control process. The incorrect patient type changes the technique factors to be used by the system without notification to the user.",
      "recall_initiation_date": "20210526",
      "center_classification_date": "20220323",
      "report_date": "20220330",
      "code_info": "Model(s) Azurion R2.1"
    }
  ]
}